Skip to content

A clinical trial to study the effect of a medical device called "Embrace Infant Warmer" against the currently available method of thermal care in low birth weight neonates.

A randomized, controlled trial to study the efficacy of Embrace Infant Warmers in maintaining thermostability of low birth weight neonates against conventional care.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2010/091/001176
Enrollment
20
Registered
2010-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Maintenance of thermostability in low birth weight neonates.

Interventions

Intervention1: Embrace Infant Warmer: Maintain thermostability in the range of 36.5 to 37.5° C during the treatment phase that lasts for 4 hours as measured by axial or skin probe method. Control Int
C during the treatment phase that lasts for 4 hours as measured by axial or skin probe method.

Sponsors

Cambree Life Improvement Technologies Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically stable neonates (not on external oxygen supply, not on IV fluids, and vital signs within the normal limit. Vital signs involve the measurement of the respiratory rate, heart rate and CRT) 2. 1500 grams to 2500 grams at time of screening 3. Gestation period greater than 32 weeks. 4. Signed and dated Informed Consent Document

Exclusion criteria

Exclusion criteria: 1. External supply of oxygen or intravenous fluids 2. Malformation that adversely affects the temperature of the neonate 3. Parental refusal to participate

Design outcomes

Primary

MeasureTime frame
Ability of the Embrace Infant Warmer to support neonatal thermostability within the range of 36.5oC to 37.5oC.Timepoint: During the study ?treatment phase?, lasting for 4 hours, as determined by axillary or skin probe temperature reading.

Secondary

MeasureTime frame
Compare the mean temperature of neonates in the study group and control group (receiving standard care)Timepoint: During the "study treatment phase", that lasts for 4 hours, and determined by axillary or skin probe temperature reading.;Efficacy of the Embrace infant warmer in maintaining temperature of the neonate within the range of 36.5oC to 37.5oCTimepoint: During the "study treatment phase", that lasts for 4 hours, and determined by axillary or skin probe temperature reading.;Maintain the temperature of the micro-environment in the Embrace Infant Warmer.Timepoint: During the "study treatment phase" that lasts for 4 hours.;Verify the sterility of the Embrace Infant Warmer when being used for multiple neonatesTimepoint: Compared to the device used in the standard of care arm before use in a neonate and immediately post removal of the neonate form the device

Countries

India

Contacts

Public ContactDR SUDHIR BORGONHA

Director

rahul@embraceglobal.org91-9538768690

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026